Medicare Enrolled
Dr. Ali Nasur, M.D.
Interventional Cardiology · El Paso, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nasur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nasur? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nasur
Dr. Ali Nasur is an interventional cardiology in El Paso, TX, with 19 years in practice. Based on federal Medicare data, Dr. Nasur performed 3,557 Medicare services across 1,962 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nasur received a total of $64,038 from 49 pharmaceutical and/or device companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nasur is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 29% volume in TX$ $64,038 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,557
Medicare services
Top 29% in TX for interventional cardiology
1,962
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~187 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 727 | $62 | $140 |
| Electrocardiogram (EKG), 12-lead | 644 | $10 | $50 |
| Echocardiogram, transthoracic | 253 | $128 | $410 |
| Regadenoson injection (Lexiscan) for heart stress test | 188 | $44 | $75 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 184 | $18 | $50 |
| Remote pacemaker/defibrillator monitoring, 90 days | 130 | $16 | $75 |
| Hospital follow-up visit, moderate complexity | 130 | $62 | $140 |
| Office visit, established patient (30-39 min) | 119 | $84 | $210 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 112 | $28 | $75 |
| Initial hospital admission, moderate complexity | 93 | $98 | $275 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 74 | $25 | $175 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $321 | $1,000 |
| Blood draw (venipuncture) | 69 | $8 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 69 | $48 | $250 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 68 | $18 | $50 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 68 | $57 | $108 |
| EKG interpretation and report | 60 | $6 | $30 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 58 | $17 | $70 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 57 | $8 | $50 |
| Remote pacemaker monitoring, 90 days | 57 | $21 | $100 |
| Programming of dual lead pacemaker system | 36 | $55 | $130 |
| Critical care, first 30-74 min | 35 | $166 | $400 |
| Office visit, established patient (10-19 min) | 32 | $29 | $90 |
| Cardiac catheterization | 28 | $200 | $600 |
| Programming evaluation of heart contractility modulator system | 27 | $57 | $80 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $127 | $380 |
| Evaluation of implantable heart and blood vessel monitoring system | 24 | $33 | $60 |
| New patient office visit (45-59 min) | 21 | $123 | $320 |
| Initial hospital admission, high complexity | 20 | $135 | $375 |
| Programming of dual lead implantable defibrillator system | 19 | $69 | $200 |
| New patient office visit, complex (60-74 min) | 19 | $126 | $400 |
| Ultrasound of leg arteries or artery grafts | 16 | $171 | $495 |
| Insertion or replacement of pulse generator and electrodes of heart contractility modulator system | 12 | $396 | $2,000 |
| New patient office visit (30-44 min) | 11 | $68 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.1% high complexity
10.4% medium
72.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$64,038
Total received (2018-2024)
Avg $9,148/year across 7 years
Top 10% in TX for interventional cardiology
49
Companies
741
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$42,569 (66.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,470 (33.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$11,702
2023$7,745
2022$14,541
2021$13,682
2020$1,520
2019$10,464
2018$4,384
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$29,512
Cardiovascular Systems Inc.
$7,130
BIOTRONIK INC.
$6,299
Medtronic, Inc.
$2,301
Impulse Dynamics (USA) Inc.
$1,982
EKOS Corporation
$1,544
Medical Device Business Services, Inc.
$1,447
Novartis Pharmaceuticals Corporation
$1,391
Bard Peripheral Vascular, Inc.
$1,277
BOSTON SCIENTIFIC CORPORATION
$1,240
Boston Scientific Corporation
$1,038
Nevro Corp.
$880
AstraZeneca Pharmaceuticals LP
$815
ABIOMED
$767
E.R. Squibb & Sons, L.L.C.
$678
Philips Electronics North America Corporation
$667
Medtronic Vascular, Inc.
$615
Biosense Webster, Inc.
$590
Boehringer Ingelheim Pharmaceuticals, Inc.
$555
PFIZER INC.
$467
Janssen Pharmaceuticals, Inc
$402
Amgen Inc.
$321
Edwards Lifesciences Corporation
$234
CARDIVA MEDICAL, INC.
$228
Abbott Laboratories
$227
CORDIS US CORP.
$215
Merck Sharp & Dohme LLC
$210
Chiesi USA, Inc.
$202
Philips North America LLC
$180
SCPHARMACEUTICALS INC.
$80
Braemar Manufacturing, LLC
$73
Lexicon Pharmaceuticals, Inc.
$72
ARBOR PHARMACEUTICALS, INC.
$43
CHIESI USA, INC.
$41
Esperion Therapeutics, Inc.
$41
Regeneron Healthcare Solutions, Inc.
$30
Gilead Sciences, Inc.
$30
AngioDynamics, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$24
Kiniksa Pharmaceuticals, Ltd.
$24
United Therapeutics Corporation
$21
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$19
Merck Sharp & Dohme Corporation
$18
Arbor Pharmaceuticals, Inc.
$17
Inari Medical, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$14
Xeris Pharmaceuticals, Inc.
$14
AltaThera Pharmaceuticals LLC
$11
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 67.1% of total payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · (5153) Azurion 5 M20 GC · (6399) Angio iFR · (6554) Periph Vasc Undiv · (6571) Eagle Eye · (6577) Visions 014 · (9285) AngioSculpt PV · (9520) IGT Devices Und · (9520) IGT Devices Undivided · (DD1) Duo Hybrid · ATTAIN COMMAND + SUREVALVE · AZURE XT DR MRI SURESCAN · Acticor · Advisa · Arcalyst · Armada 35 percutaneous catheter · Attesta · Azure · BIOFLO · BIOMONITOR · BRILINTA · Bidil · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CROME DR MRI SURESCAN · CROSSBOSS · Cardiac Monitoring Suite · CareLink Express · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Cobalt · Corlanor · Coronary Orbital Atherectomy System · CryoConsole · Diamondback Coronary · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENTRESTO · Edarbi · Edora · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · HawkOne · HeartMate 3 Left Ventricular Dev · Horizant · IN.PACT Admiral · INFINITI · Image Guided Therapy Devices _ Coronary · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · KEVEYIS · Kerendia · LEQVIO · LINQ II · LifeVest · MICRA · MYCARELINK · MYNX CONTROL · Micra · NEXLETOL · ONYX FRONTIER · OPTIMIZER · Optimizer · Optimizer Smart System · Orsiro Mission · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRIMO MRI DR SURESCAN · Passeo-18 · Penumbra Coil 400 · Penumbra System · Peripheral Orbital Atherectomy System · RAIN SHEATH · ROTABLATOR · RUBY Coil · Repatha · Resolute · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S · S.M.A.R.T. CONTROL · SELECTSITE · SYNERGY · SelectSecure · SelectSite · Senza · Solara · Solia · Sotalol Hydrochloride · SureScan · TYRX · VALEO · VENOVO · VERQUVO · VYNDAQEL · Venclose Maven Catheter · Visia AF · WATCHMAN · XARELTO · XIENCE SKYPOINT
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for interventional cardiology in TX.
Equivalent to $1,800 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
12
Per 100K population
1.4
County median income
$58,859
Nearest hospital
UNIVERSITY MEDICAL CENTER OF EL PASO
7.7 mi
7.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nasur is a electrophysiology & remote specialist, with above-average Medicare volume (top 29% in TX), and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nasur experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Nasur performed 727 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nasur receive payments from pharmaceutical companies?
Yes. Dr. Nasur received a total of $64,038 from 49 companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nasur's costs compare to other interventional cardiologys in El Paso?
Dr. Nasur's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nasur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in El Paso
Browse interventional cardiologys in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology